ISACA Expands European Presence With New Office in Dublin
9.9.2022 15:30:00 EEST | Business Wire | Press release
As a result of the continued growth and development over the last 50 years, ISACA, the global professional association advancing individuals and organizations in their pursuit of digital trust, is expanding its international reach and opening a new office in Dublin—its first European office.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220909005075/en/
Chris Dimitriadis, Chief Global Strategy Officer at ISACA (Photo: Business Wire)
ISACA´s success is defined by the passion, hard work and commitment of its more than 165,000 members in more than 180 countries worldwide. In Europe, the organization has over 30,000 members working in information and cyber security, assurance, governance, risk and privacy from different industries such as Banking & Finance, Government, Telecommunications, Engineering, Public Accounting, Education, Retail, Health, FMCG, Automotive, Utilities, Food & Beverage among others.
ISACA in Europe combines the strength and scale of a large, multi-national organization with an expert, local knowledge of the market and professional communities ISACA serves. The new office intends to facilitate cooperation between European regions, chapters and members and strengthen ISACA’s capacity to collaborate with key public and private stakeholders, as well as enterprises and academia.
“Our expanded regional presence in Europe will provide services dedicated to Europe and help extend our global reach and impact,” said ISACA CEO David Samuelson. “ISACA is both a global and a local organization, and we want to serve our professional communities where they live and work. We are very excited to have a stronger local presence in Europe to better partner with European government, enterprises, universities and our members to advance digital trust.”
The office and ISACA’s new team members in Europe will build on the strong ties that already exist between regions by promoting investment, synergies and economic opportunities to benefit members and enterprises.
Ireland’s Minister of State for eGovernment Ossian Smyth said, “We welcome ISACA’s commitment and investment into Ireland. As we continue to develop Ireland as a European hub for the digital economy and as a cyber centre of excellence, it is crucial to continue to build an expert and diverse specialist ecosystem. ISACA’s pre-eminent global work on talent development, building the cyber profession and developing tools and frameworks to underpin the next phase of technology adoption in a safe and transparent manner, will be a boost to our tech scene. We look forward to ongoing cooperation with ISACA in improving cybersecurity preparedness and resilience.”
ISACA’s European presence is led by Chris Dimitriadis, Chief Global Strategy Officer at ISACA. Dimitriadis has deep industry and ISACA experience, having served as ISACA board chair and as a past chief information security officer at a global organization.
“ISACA has a long history in Europe, and we are incredibly proud of our chapters, volunteers, members and partners in the region,” said Dimitriadis. “We are excited to strengthen our support in the communities that we serve by establishing a team of highly experienced and reputable European professionals and by opening our first office in Dublin that will strategically coordinate and support our 45 chapters in Europe and our business, government and academic partners.”
ISACA, established in 1969, is widely known for its globally recognized certifications, including Certified Information Systems Auditor (CISA) and Certified Information Security Manager (CISM), and its industry-leading frameworks, including COBIT. Additional information is at www.isaca.org/.
About ISACA
ISACA® (www.isaca.org) is a global community advancing individuals and organizations in their pursuit of digital trust. For more than 50 years, ISACA has equipped individuals and enterprises with the knowledge, credentials, education, training and community to progress their careers, transform their organizations, and build a more trusted and ethical digital world. ISACA is a global professional association and learning organization that leverages the expertise of its more than 165,000 members who work in digital trust fields such as information security, governance, assurance, risk, privacy and quality. It has a presence in 188 countries, including 225 chapters worldwide. Through its foundation One In Tech, ISACA supports IT education and career pathways for underresourced and underrepresented populations.
Twitter:
www.twitter.com/ISACANews
LinkedIn:
www.linkedin.com/company/isaca
Facebook:
www.facebook.com/ISACAGlobal
Instagram:
www.instagram.com/isacanews
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220909005075/en/
Contact information
Esther Almendros, ealmendros@isaca.org, T: +1 847-660-5777, M: +34 692 669 722
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 15:23:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR) patient populations, treatment settings, and manifestations of disease. Additionally, the data expand the potential application of RNAi to uncontrolled hypertension, the world’s leading cause of cardiovascular disease. “With the power of our RNAi therapeutics platform, we have the potential to make a transformational impact on cardiovascular care,” said Pushkal Garg, M.D., Chief Research and Development Officer at Alnylam. “The data presented at ESC demonstrate the consistency of clinical outcomes achieved by RNAi-powered TTR silencing, reinforcing our conviction in AMVUTTRA as a first-line treatment option for ATTR-CM. With
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202630.8.2026 00:54:00 EEST | Press release
Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon company, in strategic partnership with the Emirates Falconers’ Club, at ADNEC Centre Abu Dhabi. The exhibition runs until 6 September. The falcon, owned
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 01:40:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total amount of blood in the body. Maintaining controlled hematocrit levels below 45% is the primary treatment goal in PV.1 “For patients living with PV, uncontrolled hematocrit can have serious consequences, including an elevated risk of life-threatening thrombotic events," said Andrew T. Kuykendall, M.D., VERIFY lead investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “Curre
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
